Literature DB >> 8531259

Epidemic Shigella dysenteriae type 1 in Natal.

N C Rollins1, D F Wittenberg, H M Coovadia, D G Pillay, A J Karas, A W Sturm.   

Abstract

Since its first isolation in South Africa in 1994, Shigella dysenteriae type 1 has now spread to cause an epidemic outbreak in Natal Kwazulu, resulting in a steep rise in admissions for dysentery and the haemolytic uraemic syndrome in children. We report on the epidemic as it has evolved so far. A large outbreak is to be expected in South Africa in view of large scale poverty, lack of housing, and adequate water and sanitation, unless urgent public health measures are taken.

Entities:  

Mesh:

Year:  1995        PMID: 8531259     DOI: 10.1093/tropej/41.5.281

Source DB:  PubMed          Journal:  J Trop Pediatr        ISSN: 0142-6338            Impact factor:   1.165


  4 in total

1.  The spectrum of chronic kidney disease (stages 2-5) in KwaZulu-Natal, South Africa.

Authors:  Rajendra Bhimma; Miriam Adhikari; Kareshma Asharam; Catherine Connolly
Journal:  Pediatr Nephrol       Date:  2008-06-12       Impact factor: 3.714

Review 2.  Part II. Analysis of data gaps pertaining to Shigella infections in low and medium human development index countries, 1984-2005.

Authors:  P K Ram; J A Crump; S K Gupta; M A Miller; E D Mintz
Journal:  Epidemiol Infect       Date:  2007-08-09       Impact factor: 2.451

3.  Dipstick test for rapid diagnosis of Shigella dysenteriae 1 in bacterial cultures and its potential use on stool samples.

Authors:  Neelam Taneja; Faridabano Nato; Sylvie Dartevelle; Jean Marie Sire; Benoit Garin; Lan Nguyen Thi Phuong; Tai The Diep; Jean Christophe Shako; François Bimet; Ingrid Filliol; Jean-Jacques Muyembe; Marie Noëlle Ungeheuer; Catherine Ottone; Philippe Sansonetti; Yves Germani
Journal:  PLoS One       Date:  2011-10-03       Impact factor: 3.240

Review 4.  Using European travellers as an early alert to detect emerging pathogens in countries with limited laboratory resources.

Authors:  Philippe J Guerin; Rebecca Freeman Grais; John Arne Rottingen; Alain Jacques Valleron
Journal:  BMC Public Health       Date:  2007-01-19       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.